Clinical trial

Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations

NCT01246401

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-03-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2011-03-01Date precision: month

Registry last updated2020-03-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIVunresolved

AIDSunresolved

Opioid Dependenceunresolved

Drug Dependenceunresolved

Interventions

Extended-Release NaltrexoneDRUG

Sponsors & collaborators

Yale Universitylead sponsor

Baystate Medical Centercollaborator

National Institute on Drug Abuse (NIDA)collaborator

Mapped research locations

New HavenConnecticut, United States1 HartfordConnecticut, United States1 SpringfieldMassachusetts, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01246401 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.